Get the Stockscreener App
375.21
1.54%
-6.145
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $375.21, with a volume of 688.60K.
It is down -1.54% in the last 24 hours and up +8.58% over the past month.
See More
Previous Close:
$381.36
Open:
$379.13
24h Volume:
688.60K
Relative Volume:
0.44
Market Cap:
$139.34B
Revenue:
$23.22B
Net Income/Loss:
$2.86B
P/E Ratio:
50.70
EPS:
7.4
Net Cash Flow:
$3.58B
1W Performance:
+1.23%
1M Performance:
+8.58%
6M Performance:
+1.75%
1Y Performance:
+15.35%
1-Day Range:
$373.98
$381.57
1-Week Range:
$363.08
$383.99
52-Week Range:
$314.93
$406.19
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 389-2600
Address
2825 AIRVIEW BLVD, KALAMAZOO, MI
Compare SYK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
375.27 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
ABT
Abbott Laboratories
|
132.01 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.79 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
82.43 | 107.01B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.73 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Stryker, Lockheed Martin, Rockwell Automation And More On CNBC's 'Final Trades' - Benzinga
Stryker (SYK) Price Target Raised by Truist Securities | SYK Stock News - GuruFocus
UBS lifts Stryker stock price target to $421 from $405 - Investing.com
Demystifying Stryker: Insights From 5 Analyst Reviews - Benzinga
Stryker's (SYK) Price Target Raised by Truist Amid Strong Growth | SYK Stock News - GuruFocus
Stryker (SYK) Receives Price Target Boost Following Strong Quarterly Results | SYK Stock News - GuruFocus
Decoding Stryker Corp (SYK): A Strategic SWOT Insight - GuruFocus
Stryker Corp’s Earnings Call Highlights Robust Growth - TipRanks
Stryker price target raised to $456 from $405 at Roth Capital - TipRanks
Stryker says bribery probe dropped by US Justice Department - MLex
Stryker (SYK) Lands a Higher Price Target from Roth MKM | SYK Stock News - GuruFocus
Stryker (SYK) Rating Maintained, Price Target Lowered by Evercore ISI Group | SYK Stock News - GuruFocus
Medical Equipment Makers Stryker, Becton Eye Price Hikes to Offset Tariffs - Bloomberg.com
Stryker (SYK): Roth Capital Boosts Price Target Amid Strong Q1 P - GuruFocus
Stryker raises forecast on strong sales despite $200M tariff hit - Crain's Grand Rapids Business
Stryker Corporation (SYK) Sees Strong Q1 2025 Growth Amid Strate - GuruFocus
Stryker Corporation (NYSE:SYK) Q1 2025 Earnings Call Transcript - Insider Monkey
Stryker stock target cut to $390 by Evercore ISI - Investing.com
Stryker beats quarterly estimates of string medical device demand - Reuters
Stryker Corp Reports Strong Q1 2024 Earnings Growth - TipRanks
Stryker Corp (SYK) Q1 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ... - Yahoo Finance
Stryker Corp (SYK) Q1 2025 Earnings: Revenue Surpasses Estimates at $5.9 Billion, EPS Falls Short at $1.69 - GuruFocus
Stryker Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Stryker: Q1 Earnings Snapshot - MySA
Stryker Corporation (SYK) Sees Strong Q1 2025 Growth Amid Strategic Shifts - GuruFocus
Stryker's Profits Outshine Forecasts Thanks To Device Demand - Finimize
Earnings call transcript: Stryker Q1 2025 beats EPS forecasts, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: Stryker Q1 2025 beats EPS forecasts, stock dips - Investing.com
Stryker reports first quarter 2025 operating results - ADVFN
Stryker (SYK) Surpasses Q1 Earnings and Revenue Estimates - Yahoo
Stryker earnings beat by $0.13, revenue topped estimates - Investing.com
Stryker beats Q1 estimates, raises 2025 organic sales outlook By Investing.com - Investing.com India
Stryker beats Q1 estimates, raises 2025 organic sales outlook - Investing.com
Stryker Corp. Q1 Profit Decreases, But Beats Estimates - Nasdaq
Here's How Much $1000 Invested In Stryker 10 Years Ago Would Be Worth Today - Benzinga
Global Spinal Stenosis Devices Market to reach USD 4,131.08 million at a CAGR of 4.83% by 2030, Evaluates DelveInsight | Spinal Simplicity, Boston Scientific Corporation, Medtronic, Stryker, Surgalig - Barchart.com
Stryker (SYK) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Stryker to participate in the Bank of America Securities 2025 Global Healthcare Conference - Yahoo Finance
Stryker Corporation (SYK): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential - Insider Monkey
Stryker (SYK) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Stryker Corp (SYK) Stock Price Up 3.26% on Apr 23 - GuruFocus
Paul Harris' Past Picks: Stryker, Essilor Luxottica & Novo Nordisk - BNN Bloomberg
TD Cowen maintains Stryker stock Buy rating, $435 target - Investing.com
TD Cowen maintains Stryker stock Buy rating, $435 target By Investing.com - Investing.com UK
Stryker accuses German rival Fiagon of patent infringement at USITC - MLex
Stryker Corporation (SYK): A Bull Case Theory - MSN
William Schamel Stryker - San Diego Union-Tribune
Here's What to Expect From Stryker Corporation's Next Earnings Report - Nasdaq
Here's What To Expect From Stryker Corporation's Next Earnings Report - Barchart.com
Fed. Circ. Won't Revive Stryker Unit's Antiseptic Patents - Law360
Federal Circuit Axes Stryker Unit’s Sterilized Wipe Patents - Bloomberg Law News
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
2.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):